0 participants
Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-06-18
- Start Date:
- 2020-04-07
- Completion:
- 2020-06-02
Conditions
- Cerebrovascular Accident
- Chronic Obstructive Pulmonary Disease
- Chronic Renal Failure
- Coronary Artery Disease
- Diabetes Mellitus
- Malignant Neoplasm
- SARS Coronavirus 2 Infection
Interventions
- OTHER
- BIOLOGICAL
No Results Yet